Jiangxi Rimag Group Co., Ltd. Class H ( (HK:2522) ) has shared an update.
Jiangxi Rimag Group Co., Ltd. has issued a profit warning, anticipating a net loss of RMB55.0 million to RMB60.0 million for FY2024, compared to a net profit of RMB36.6 million in FY2023. The decline is attributed to a challenging macroeconomic environment, reduced demand from medical institutions, and expenses related to its listing on the Hong Kong Stock Exchange. The company has postponed the delivery of certain imaging solutions and the operation of new imaging centers to 2025, impacting its revenue for FY2024.
More about Jiangxi Rimag Group Co., Ltd. Class H
Jiangxi Rimag Group Co., Ltd. operates in the medical imaging industry, providing imaging solutions and establishing imaging centers. The company focuses on serving various medical institutions.
YTD Price Performance: -57.39%
Average Trading Volume: 153,336
Technical Sentiment Consensus Rating: Strong Buy
Find detailed analytics on 2522 stock on TipRanks’ Stock Analysis page.